Chronic kidney disease: a public health priority and harbinger of premature cardiovascular disease. - Wikidata - awgldk - TriplyDB

Chronic kidney disease: a public health priority and harbinger of premature cardiovascular disease.

Chronic kidney disease: a public health priority and harbinger of premature cardiovascular disease.

http://www.wikidata.org/entity/Q37784542

about

Multicenter epidemiological study to assess the population of CKD patients in Greece: results from the PRESTAR study Macrophage Migration Inhibitory Factor in Clinical Kidney Disease Prognostic effect of high-flux hemodialysis in patients with chronic kidney disease Calcium regulation and bone mineral metabolism in elderly patients with chronic kidney disease Developments in renal pharmacogenomics and applications in chronic kidney disease Role of cytogenetic biomarkers in management of chronic kidney disease patients: A review Extracts of Magnolia Species-Induced Prevention of Diabetic Complications: A Brief Review Crosstalk between the unfolded protein response and NF-κB-mediated inflammation in the progression of chronic kidney disease Immunoglobulin (Ig)M antibodies against oxidized cardiolipin but not native cardiolipin are novel biomarkers in haemodialysis patients, associated negatively with mortality Serum resistin and kidney function: a family-based study in non-diabetic, untreated individuals Alkaline phosphatase: a novel treatment target for cardiovascular disease in CKD.An adsorbent monolith device to augment the removal of uraemic toxins during haemodialysis.Erectile dysfunction and risk of end stage renal disease requiring dialysis: a nationwide population-based study.Serum Non-High-Density Lipoprotein Cholesterol and Risk of Cardiovascular Disease in Community Dwellers with Chronic Kidney Disease: the Hisayama Study Pharmacological and genetic depletion of fibrinogen protects from kidney fibrosis.Evidence for anti-inflammatory effects of exercise in CKD.Application of creatinine- and/or cystatin C-based glomerular filtration rate estimation equations in elderly Chinese.Renal function is a determinant of subjective well-being in active seniors but not in patients with subjective memory complaints.Association of high blood pressure with renal insufficiency: role of albuminuria, from NHANES, 1999-2006.Emerging drugs for chronic kidney disease.Premature aging of the microcirculation in patients with advanced chronic kidney disease Elevated circulating levels and tissue expression of pentraxin 3 in uremia: a reflection of endothelial dysfunction.The incidence of albuminuria after bariatric surgery and usual care in Swedish Obese Subjects (SOS): a prospective controlled intervention trial.Metabolic changes in summer active and anuric hibernating free-ranging brown bears (Ursus arctos).Differentiation of human pluripotent stem cells into nephron progenitor cells in a serum and feeder free system.Uremia alters HDL composition and function Uric acid as a mediator of diabetic nephropathy.The role of plasma triglyceride/high-density lipoprotein cholesterol ratio to predict cardiovascular outcomes in chronic kidney disease Associations between Thyroid Hormones, Calcification Inhibitor Levels and Vascular Calcification in End-Stage Renal Disease.Renal disease in HIV-infected individuals Immunization of AGE-modified albumin inhibits diabetic nephropathy progression in diabetic mice PCSK9 Plasma Concentrations Are Independent of GFR and Do Not Predict Cardiovascular Events in Patients with Decreased GFR Early chronic kidney disease: diagnosis, management and models of care End stage and chronic kidney disease: associations with renal cancer.The multifaceted roles of neutrophil gelatinase associated lipocalin (NGAL) in inflammation and cancer High prevalence of isolated nocturnal hypertension in Chinese patients with chronic kidney disease.Small dense low-density lipoprotein cholesterol was associated with future cardiovascular events in chronic kidney disease patients.Quality of life in patients on chronic dialysis in South Africa: a comparative mixed methods study.Add-on Protective Effect of Pentoxifylline in Advanced Chronic Kidney Disease Treated with Renin-Angiotensin-Aldosterone System Blockade - A Nationwide Database Analysis.A trial of 2 strategies to reduce nocturnal blood pressure in blacks with chronic kidney disease.

P2860

Q21131891-B7AF1A6B-4F0E-45A8-84F9-5617B02AC22A Q26767479-CE14EC08-22DB-476B-AEF1-1E883AB47BF3 Q26775524-E11749FD-5A76-4F6E-89E3-C3F42D958688 Q26863412-49CCBC54-6DD1-4E97-B56C-FB6C25019D9B Q26999279-13EAE7BC-4A47-4339-8A63-6D9CA80712F5 Q28069800-671ADCC9-7BDF-4EDC-AF70-314F03155346 Q28073215-AF07AFB1-C312-4EF6-959F-DBD8764FDAC5 Q28080433-D7198B6A-5A68-4D84-94F4-8D6F3F6E5CBE Q28390958-786F0C28-5B0B-4286-9385-D90FAD66491F Q28728576-951616AD-4CDB-4331-96D7-37F1AB5EEAD4 Q30234466-BA92E7DD-A38C-45EF-BF3B-98BE77412EF6 Q33663437-081ECD1E-A4A1-47EA-9BDC-45D4BDB6499C Q33889861-9FE9E3BE-F58C-4B42-AE2B-A8DC800219B9 Q33918753-7F66DBC7-2DBF-4AD2-95E3-81CEDB72446C Q34062853-27581AA6-10FB-473F-B76A-B832F544CA4C Q34103416-E5D7408F-5D7F-46CE-AE33-CB9CB1DE76B0 Q34198698-F509C5AD-1703-4803-851B-E29AB0CED526 Q34254221-68BF9F3D-8DD6-4B48-8945-FB27D6BCE5B2 Q34339595-80F3A9ED-25B4-4F6A-9A10-8A947528183F Q34420383-B269A5BB-1953-49F2-8B27-B29137A0110E Q34513907-B54A3141-3BD2-418C-8D39-92A2D41254D0 Q34713240-0465B342-A2C3-4351-B359-B33FE319808E Q34848978-6D2B64C0-27B2-4DF3-9699-DC88B5E0E487 Q34988670-18FD1F96-DB00-4653-B186-E1452B469346 Q35146986-A13798E3-05D3-4876-9E03-F0E906EBE7AC Q35210194-F370752F-E02F-4EA7-9008-D606C42CDC53 Q35393446-D3B786EB-AD77-4F98-B0BB-4C5E07998C4E Q35530832-6BAAD931-CA23-4F82-AF56-538AF3341957 Q35684042-1B26E6AB-577F-46B9-B6F8-C13A01C5D1F7 Q35698442-63D8B2FE-907E-434B-875E-A6FFE8D7AD02 Q35766118-74941CC7-A9B9-4ED7-9279-03E2B0776370 Q35901123-4920046D-DAA1-4341-8F89-FE3B35608C9E Q35938045-0239DC73-9683-4477-9710-3C9623947A3F Q35971255-A6B726AC-4CD7-4D2C-9E1C-9EBEB83C20DA Q35996059-53624D55-6F84-4AEE-A91C-63B5308B77CA Q36142032-A5F027A3-3E0C-43F8-BA1C-6C1CD819B067 Q36156630-EC1DC7F9-3E76-422E-BB69-8A771389E9A1 Q36240900-94AB683F-B3F1-4FE4-9F60-3A84418FD931 Q36323673-CEBD72C0-A867-4E78-9923-2E336E6E34D5 Q36470706-CA5213D8-EF06-48B9-A9BA-FECB4B9C6E68

P2860

Chronic kidney disease: a public health priority and harbinger of premature cardiovascular disease.

http://www.wikidata.org/entity/Q37784542

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

2010年學術文章

@zh

2010年學術文章

@zh-hant

name

Chronic kidney disease: a publ ...... mature cardiovascular disease.

@en

Chronic kidney disease: a publ ...... mature cardiovascular disease.

@nl

type

label

Chronic kidney disease: a publ ...... mature cardiovascular disease.

@en

Chronic kidney disease: a publ ...... mature cardiovascular disease.

@nl

prefLabel

Chronic kidney disease: a publ ...... mature cardiovascular disease.

@en

Chronic kidney disease: a publ ...... mature cardiovascular disease.

@nl

P1433

Q37784542-AA23759C-5A36-4045-8231-8011E5257267

P1476

Q37784542-738E1278-6D90-4AB7-A846-B9E8CA95FB9F

P2860

Q37784542-1701C871-22BA-477F-AA50-16A34AC6BD74

Q37784542-4CC6D863-CC80-4E47-A251-AA71656ED997

Q37784542-BC26DEB5-4579-44CF-A160-DD833FBF06B6

P304

Q37784542-E213A595-6720-4CBD-AB28-7540EF04B39B

P31

Q37784542-C63DB809-527B-48D7-9409-ACE63BA781EF

P356

Q37784542-F228DF93-7360-43EC-9F6C-10287E3C41D5

P407

Q37784542-681DC797-6C5F-4F4A-98A4-C30944B4F2D5

P433

Q37784542-57F71815-D12D-43E7-B40E-9510E17A497C

P478

Q37784542-86ECF0D9-83F9-4948-A825-4245A2940E65

P50

Q37784542-BAE6A3F8-E0FB-4732-982D-767278E3F4BD

P577

Q37784542-A5A97625-A260-42D5-82EB-98D7DB8B5ABB

P5875

Q37784542-DA1EAE4D-739C-4A9C-9239-6CBEAE0C4954

P698

Q37784542-805B8A56-FE1F-4C6B-8F5D-99C860AC02A0

P921

Q37784542-1473C406-99EC-4585-8EA2-C76A5746B18B

Q37784542-62B073D9-86E9-4E06-958B-95645057B481

P356

J.1365-2796.2010.02269.X

P1433

Journal of Internal Medicine

P1476

Chronic kidney disease: a publ ...... mature cardiovascular disease.

@en

P2860

Inflammation in end-stage renal disease--what have we learned in 10 years?

The incidence of end-stage renal disease is increasing faster than the prevalence of chronic renal insufficiency.

Body mass index and risk for end-stage renal disease.

P304

456-467

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1365-2796.2010.02269.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

268

http://www.w3.org/2001/XMLSchema#string

P50

Peter Stenvinkel

P577

2010-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

46109653

http://www.w3.org/2001/XMLSchema#string

P698

20809922

http://www.w3.org/2001/XMLSchema#string

P921

cardiovascular disease